Mercia Ventures led a $15m Series B round in Semble.

Mercia Ventures, a venture capital firm, led a $15m Series B round in Semble, a healthTech software company, with participation from Octopus Ventures, Smedvig Ventures, and Triple Point. “Amplifying the impact of healthcare professionals is central to our mission. For too long, they have worked with outdated systems that take them away from what matters most – the patient. With this latest funding, we are looking to bring Semble to professionals across the UK and France, empowering them to spend more time on patient care. We will continue to invest heavily in workflow automation and integrations, positioning Semble at the forefront of AI-driven solutions, and ultimately creating a more connected healthcare ecosystem,” Christoph Lippuner, Semble CEO.